tirzepatide & semaglutide Shows Superior Weight Loss Over in Phase 3 Trial TrimRX | Semaglutide vs Tirzepatide:

BPC-157 is not a controlled substance, so possessing it is not illegal

Semaglutide is available in several formulations approved by the US Food and Drug Administration (FDA): Ozempic: approved for type 2 diabetes but often prescribed off-label for weight loss under medical supervision Wegovy: specifically approved for weight management in adults with obesity or overweight with related health conditions Rybelsus: the oral (pill) version of semaglutide, taken daily rather than by weekly injection Each option has different dosages and indications, and our endocrinologists help you determine which if any best fits your health profile

Additional Phase 3 readouts including TRIUMPH-2, TRIUMPH-3, and the cardiovascular outcomes trial are due through 2026

MOTS-c: Research protocols for MOTS-c, often involve subcutaneous injections 2-3 times weekly, with doses ranging from 5-15 mg in informal research discussions